Barrera, J., Brake, D. A., Schutta, C., Ettyreddy, D., Kamicker, B. J., Rasmussen, M. V., Bravo de Rueda, C., Zurita, M., Pisano, M., Hurtle, W., Brough, D. E., Butman, B. T., Harper, B. G., & Neilan, J. G. (2018). versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine. Vaccine, 36(48), 7345–7352. http://access.bl.uk/ark:/81055/vdc_100072160573.0x000041